| Literature DB >> 20723645 |
Francisco J Pastor-Pérez1, Sergio Manzano-Fernández, Rebeca Goya-Esteban, Domingo A Pascual-Figal, Oscar Barquero-Pérez, Jose Luis Rojo-Alvarez, Maria Dolores Martinez Martinez-Espejo, Mariano Valdés Chavarri, Arcadio García-Alberola.
Abstract
The purpose of this study was to compare the diagnostic sensitivity of 1-day Holter monitoring versus 7-day Holter monitoring (7DH) to detect atrial and ventricular arrhythmias in a population of stable patients with chronic heart failure and left ventricular dysfunction. Sixty-three consecutive stable patients with chronic heart failure with left ventricular ejection fractions < or =50% were included. Blood samples were obtained, the Minnesota Living With Heart Failure Questionnaire was administered, and echocardiography, 6-minute walk tests, and 7DH were performed at enrollment. The mean ejection fraction was 35.8 +/- 9.8%, and the mean age was 55.5 +/- 13.9 years. Seven-day Holter monitoring did not significantly increase the detection of nonsustained atrial tachycardia or atrial fibrillation. In contrast, the incidence of nonsustained ventricular tachycardia increased in nonischemic patients from 35.1% on day 1 to 54.1% on day 7 (p = 0.01). In ischemic patients, the sensitivity increased from 11.5% to 46.2% (p = 0.004). Two patients without nonsustained ventricular tachycardia on day 1 had episodes of 13 and 16 beats on days 3 and 6 of monitoring. In patients with left ventricular ejection fractions >35% and N-terminal-pro-brain natriuretic peptide levels <1,000 pg/ml, no episodes of nonsustained ventricular tachycardia were detected on day 1 in nonischemic and ischemic patients, but 7DH detected 3 new patients in each group. In conclusion, 7DH clearly improves the detection and allows a better characterization of ventricular arrhythmic episodes but seems to be less useful for supraventricular events. 2010 Elsevier Inc. All rights reserved.Entities:
Mesh:
Year: 2010 PMID: 20723645 DOI: 10.1016/j.amjcard.2010.04.027
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778